@FiercePharma: Would Pfizer break-up leave a healthier core? News | Follow @FiercePharma
> The FDA says it has approved Tradjenta, a new diabetes pill from Boehringer Ingelheim and Eli Lilly, for patients who can't control their blood sugar with older medicines. Report
> Watson Pharmaceuticals said it has started selling an authorized generic version of Johnson & Johnson's attention deficit hyperactivity disorder drug Concerta. News
> Nycomed is considering establishing its own high-tech production in Ukraine and expects to decide by year's end whether to sink €35 million into the project. Story
> Acura Pharmaceuticals named Robert Jones as its interim president and CEO Monday following the death of president and CEO Andrew Reddick last week. Article
> AstraZeneca said Mark Mallon had been appointed as president of AstraZeneca China, effective May 1. Item
> Genzyme and its Cambridge, MA, landlord have won a $1.5 million tax abatement for the company's iconic headquarters building near Kendall Square. Report
> Montana Gov. Brian Schweitzer said he would allow a controversial bill restricting the state's medical-marijuana business to become law without his signature. Article
> Bosch Packaging Technology is planning to expand its position in the pharmaceutical processing equipment sector with the purchase of two of Oystar's business units. Story
> An Abbott Laboratories unit sued generic drugmaker Teva Pharmaceuticals USA for patent infringement with its plans to market a copy of Abbott's AndroGel testosterone preparation. Item
> AstraZeneca said that U.S. regulators approved an injectable version of its heartburn drug Nexium for use in infants as young as a month old. News
Biotech News
@FierceBiotech: Teva elbows aside Valeant with $6.8B buyout deal for Cephalon. Item | Follow @FierceBiotech
@JohnCFierce: Wilex gets $19 million for U.S. licensing rights to renal cell cancer drug Rencarex. Story | Follow @JohnCFierce
> Vivus eyes path to a limited approval for obesity drug. Item
> Next-gen addiction vaccines offer a tough challenge to biotechs. Article
> Clinical, regulatory jobs top biotech's "must-hire" list. Story
> Pfizer, Icagen recruit Yale scientists for pain collaboration. Report
Biotech Research News
> Paralyzed man reports sensations after embryonic stem cell treatment. Article
> Researchers can erase traumatic memories in snails ... humans next? Item
> Artificial nose can quickly sniff out bacterial infections. Story
> Cancer-fighting compounds found under the sea. News
> Newly discovered genes could lead to earlier glaucoma diagnosis. Report
> Why was U.S. so sure it had Osama bin Laden's DNA? Story
Manufacturing News
> Generics makers position for world domination. Story
> ABC, Cardinal see growth in specialty pharma. Item
> ISP passes ingredient price hikes on to drugmakers. Article
> Bayer tweaks anti-counterfeiting tactics. Report
> Accenture IT fix for quality misses key point. News
And Finally... A study published in the American Journal of Psychiatry suggests that newly depressed patients shouldn't start with two drugs: Combination therapy appeared to be no more effective than a single drug in improving depression symptoms. Report